Biography:
Mr. Edward Tichivangani, a final-year student in the Biotechnology and Bioinformatics programme at Midlands State University, stated that his research focuses on the in silico repurposing of FDA-approved compounds for the dual targeting of HER2 and EGFR. He expressed his gratitude for the consideration of his application and mentioned that he looked forward to being part of the initiative.
Title : In silico repurposing of FDA approved drug compounds for dual targeting of HER2 and EGFR